Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 44,319 | 36,161 | 34,366 | 15,735 | 29,806 |
| Cost of Goods | 5,708 | 3,491 | 4,925 | 4,308 | 6,809 |
| Gross Profit | 38,611 | 32,670 | 29,441 | 11,427 | 22,997 |
| Operating Expenses | 127,367 | 109,252 | 96,517 | 105,392 | 102,030 |
| Operating Income | -88,048 | -76,091 | -66,151 | -93,657 | -78,224 |
| Interest Expense | 3,069 | 2,372 | 1,118 | 84 | 141 |
| Other Income | 2,652 | 1,036 | 921 | 1,798 | 5,199 |
| Pre-tax Income | -88,465 | -77,427 | -66,348 | -91,943 | -73,166 |
| Income Tax | -235 | 74 | 108 | 114 | 23 |
| Net Income Continuous | -87,680 | -76,705 | -66,175 | -91,650 | -72,624 |
| Net Income | $-87,680 | $-76,705 | $-66,175 | $-91,650 | $-72,624 |
| EPS Basic Total Ops | -22.50 | -20.25 | -17.50 | -24.50 | -19.50 |
| EPS Basic Continuous Ops | -22.43 | -20.25 | -17.61 | -24.44 | -19.42 |
| EPS Diluted Total Ops | -22.50 | -20.25 | -17.50 | -24.50 | -19.50 |
| EPS Diluted Continuous Ops | -22.43 | -20.25 | -17.61 | -24.44 | -19.42 |
| EBITDA(a) | $-86,462 | $-73,815 | $-63,684 | $-90,648 | $-74,989 |